Victory Capital Management
DNTH icon

Victory Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

Victory Capital Management’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.61M Buy
88,315
+72,653
+464% +$6.35M ﹤0.01% 1185
2026
Q1 		$1.31M Buy
15,662
+872
+6% +$50.5K ﹤0.01% 1731
2025
Q4 		$609K Buy
+14,790
New +$573K ﹤0.01% 1985
2020
Q2 		– Sell
-221
Closed -$22K – 2720
2020
Q1 		$22K Buy
+221
New +$41K ﹤0.01% 2810
2019
Q4 		– Sell
-187
Closed -$31K – 2811
2019
Q3 		$31K Buy
+187
New +$35.5K ﹤0.01% 2890

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Victory Capital Management's DNTH Position: Q2 2026 in Review

Victory Capital Management increased its Dianthus Therapeutics (DNTH) stake by 464% in Q2 2026, buying an estimated $6.35M and bringing the position to 88,315 shares worth $8.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1185.

Victory Capital Management first reported a position in DNTH in Q3 2019 and has held it in 5 quarters since. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

  • Victory Capital Management held 88,315 shares of Dianthus Therapeutics worth $8.61M as of Q2 2026.
  • Victory Capital Management bought 72,653 Dianthus Therapeutics shares in Q2 2026, an estimated $6.35M.
  • Dianthus Therapeutics made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1185 holding.
  • Victory Capital Management first reported a position in Dianthus Therapeutics in Q3 2019 and has held it in 5 quarters since.
  • 270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.